Johnson & Johnson divests six OTC skin care brands to Valeant Pharmaceuticals International Inc. as part of its “ongoing portfolio management process,” according to a statement. In the deal completed in October, Montreal-based Valeant gained Ambi lotions and cleansers, Caladryl and Cortaid anti-itch products, Corn Huskers hand treatment lotion, Purpose sensitive skin care products and Shower to Shower body powder, all in North America, Latin America and most Asia-Pacific markets. During Valeant’s third-quarter earnings call Nov. 2, CEO J. Michael Pearson said the acquired products “are well-recognized brands and should continue to deliver strong cash flows.” Valeant seeks to build on its OTC dermatology business, which includes CeraVe cleansers and moisturizers and the AcneFree line ([A#05120702002]).
FDA finds products online making anti-meningitis claims, following meningitis infections linked to fungal contamination of an Rx compound produced and...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?